Search Results
31 items found for "Kai Schulze-Forster"
Posts (14)
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
researchers: AI solutions which bring together theoretical, computational, and experimental labs will allow faster
- 📰 GPCR Weekly News, July 24 to July 30, 2023
Lukas Grätz, David Gloriam, and Gunnar Schulte’s research on Unveiling pathway selectivity in Frizzleds Then, join us on September 22nd for our discussion session, formerly known as The poster session, on
- 📰 GPCR Weekly News, February 5 to 11, 2024
Magdalena M Scharf, Antonella Di Pizio, Ines Liebscher, Hannes Schihada, and Gunnar Schulte et al. on We will also have a poster session in breakout rooms on Zoom; if you are interested in sharing your work
Other Pages (17)
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
I Gaede , Howard Amital , Philip Rosenstiel , Yehuda Shoenfeld , Gilad Halpert , Avi Z Rosenberg , Kai Schulze-Forster , Harald Heidecke , Gabriela Riemekasten , Stefan Schreiber .
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
Authors Mor Oron-Herman , David Kirmayer , Amelie Lupp , Stefan Schulz , Genady Kostenich , Michel Afargan
- Ep 46 with Dr Gunnar Schulte
Gunnar Schulte About Dr. Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and General Research Interest: The focus in the Schulte lab is on Frizzled signaling and pharmacology aiming Gunnar Schulte on the web Schulte Lab LinkedIn Google Scholar Orcid YouTube Dr.